Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy

Gopalakrishna Iyer, N.; G.T. Morris, Luc; Michael Tuttle, R.; R. Shaha, Ashok; Ganly, Ian

doi:10.1002/cncr.26070

Public

Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy

Published in Cancer • Mar 22, 2011

Authors:

N. Gopalakrishna Iyer

Luc G.T. Morris

R. Michael Tuttle

Abstract

BACKGROUND: American Thyroid Association guidelines currently recommend the selective use of radioactive iodine (RAI) therapy in patients with well differentiated thyroid cancer (WDTC). Despite these guidelines, RAI ablation has been used routinely in all but the very lowest risk patients with thyro...

Subject

Medicine

Thyroid cancer

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!